Corresponding Author: Carol M. Mangione, MD, MSPH, David Geffen School of Medicine, University of California, Los Angeles, 10940 Wilshire Blvd, Ste 700, Los Angeles, CA 90024 (email@example.com).
Accepted for Publication: September 1, 2022.
Published Online: October 11, 2022. doi:10.1001/jama.2022.16946
The US Preventive Services Task Force (USPSTF) Members: Carol M. Mangione, MD, MSPH; Michael J. Barry, MD; Wanda K. Nicholson, MD, MPH, MBA; Michael Cabana, MD, MA, MPH; David Chelmow, MD; Tumaini Rucker Coker, MD, MBA; Karina W. Davidson, PhD, MASc; Esa M. Davis, MD, MPH; Katrina E. Donahue, MD, MPH; Carlos Roberto Jaén, MD, PhD, MS; Martha Kubik, PhD, RN; Li Li, MD, PhD, MPH; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; John M. Ruiz, PhD; Michael Silverstein, MD, MPH; James Stevermer, MD, MSPH; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) Members: University of California, Los Angeles (Mangione); Harvard Medical School, Boston, Massachusetts (Barry); University of North Carolina at Chapel Hill (Nicholson, Donahue); Albert Einstein College of Medicine, New York, New York (Cabana); Virginia Commonwealth University, Richmond (Chelmow); University of Washington, Seattle (Coker); Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York (Davidson); University of Pittsburgh, Pittsburgh, Pennsylvania (Davis); The University of Texas Health Science Center, San Antonio (Jaén); George Mason University, Fairfax, Virginia (Kubik); University of Virginia, Charlottesville (Li); New York University, New York, New York (Ogedegbe); University of Massachusetts Chan Medical School, Worcester (Pbert); University of Arizona, Tucson (Ruiz); Brown University, Providence, Rhode Island (Silverstein); University of Missouri, Columbia (Stevermer); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Mangione had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Iris Mabry-Hernandez, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The US Preventive Services Task Force (USPSTF) makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms. Published by JAMA®—Journal of the American Medical Association under arrangement with the Agency for Healthcare Research and Quality (AHRQ). ©2022 AMA and United States Government, as represented by the Secretary of the Department of Health and Human Services (HHS), by assignment from the members of the United States Preventive Services Task Force (USPSTF). All rights reserved.
M , Wallace
I , Middleton
et al. Screening for Depression, Anxiety, and Suicide Risk in Children and Adolescents: An Evidence Review for the US Preventive Services Task Force. Evidence Synthesis No. 221. Agency for Healthcare Research and Quality; 2022. AHRQ publication 22-05293-EF-1.
M , Wallace
IF , Cook Middleton
et al. Screening for depression and suicide risk in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA
. Published online October 11, 2022. doi:10.1001/jama.2022.16310Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.
AE , Ortega
L , Melanson
C . Self-Directed Violence Surveillance: Uniform Definitions and Recommended Data Elements. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2011.
DL , Calhoun
CD , Banks
DE , Halliday
CA , Hughes-Halbert
C , Danielson
CK . Making the “C-ACE” for a culturally-informed adverse childhood experiences framework to understand the pervasive mental health impact of racism on Black youth. J Child Adolesc Trauma
. 2020;14(2):233-247. doi:10.1007/s40653-020-00319-9PubMedGoogle ScholarCrossref
KR , He
JP , Burstein
et al. Service utilization for lifetime mental disorders in US adolescents: results of the National Comorbidity Survey–Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry
. 2011;50(1):32-45. doi:10.1016/j.jaac.2010.10.006PubMedGoogle ScholarCrossref
J , Silva
S , Petrycki
et al; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA
. 2004;292(7):807-820. doi:10.1001/jama.292.7.807PubMedGoogle ScholarCrossref
SN , Stasiak
K , Shepherd
M , Frampton
C , Fleming
T , Lucassen
MF . The effectiveness of SPARX, a computerised self help intervention for adolescents seeking help for depression: randomised controlled non-inferiority trial. BMJ
. 2012;344:e2598. doi:10.1136/bmj.e2598PubMedGoogle ScholarCrossref
D , McIntosh
M . The role of primary care physicians in detection and treatment of adolescent mental health problems. In: Evans
DL , Foa
EB , Gur
et al, eds. Treating and Preventing Adolescent Mental Health Disorders: What We Know and What We Don’t Know: A Research Agenda for Improving the Mental Health of Our Youth. 2nd ed. Oxford University Press; 2012.
US Preventive Services Task Force. Screening for anxiety in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA
. Published October 11, 2022. doi:10.1001/jama.2022.16936Google Scholar
US Preventive Services Task Force. Primary care–based interventions to prevent illicit drug use in children, adolescents, and young adults: US Preventive Services Task Force recommendation statement. JAMA
. 2020;323(20):2060-2066. doi:10.1001/jama.2020.6774PubMedGoogle ScholarCrossref
US Preventive Services Task Force. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force recommendation statement. JAMA
. 2018;320(18):1899-1909. doi:10.1001/jama.2018.16789PubMedGoogle ScholarCrossref
ML ; US Preventive Services Task Force. Screening for suicide risk in adolescents, adults, and older adults in primary care: US Preventive Services Task Force recommendation statement. Ann Intern Med
. 2014;160(10):719-726. doi:10.7326/M14-0589PubMedGoogle ScholarCrossref
AL ; US Preventive Services Task Force. Screening for depression in children and adolescents: US Preventive Services Task Force recommendation statement. Ann Intern Med
. 2016;164(5):360-366. doi:10.7326/M15-2957PubMedGoogle ScholarCrossref
JG , Harris
ES , Spitzer
RL , Williams
JB . The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health
. 2002;30(3):196-204. doi:10.1016/S1054-139X(01)00333-0PubMedGoogle ScholarCrossref
RA , Cheung
A , Jensen
PS , Stein
REK , Laraque
D ; GLAD-PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): part I: practice preparation, identification, assessment, and initial management. Pediatrics
. 2018;141(3):e20174081. doi:10.1542/peds.2017-4081PubMedGoogle ScholarCrossref
HL , Patterson
CJ , Wathen
et al; Canadian Task Force on Preventive Health Care. Screening for depression in primary care: recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ
. 2005;172(1):33-35. doi:10.1503/cmaj.1030823PubMedGoogle ScholarCrossref